Estrogen therapy for depression in postmenopausal women

International Journal of Gynecology and Obstetrics

Volumn 65, Issue 1, 1999, Pages 35-38

  Carranza Lira, S ^a,b   Valentino Figueroa, M L ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b NONE   (Mexico)

Author keywords

Climactery; Conjugated equine estrogens; Depressive mood; Estrogen replacement therapy; Postmenopause

Indexed keywords

CONJUGATED ESTROGEN;

ADULT; ARTICLE; CLIMACTERIUM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFICACY; ESTROGEN THERAPY; FEMALE; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0032958143     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(99)00017-X     Document Type: Article

References (20)

1. Carranza LS. Cuadro clínico y diagnóstico (Clinical data and diagnosis). In: Carranza LS, editor. Atención integral del climaterio (Integral attention of the climactery). México: McGraw-Hill Interamericana, 1998:19-28.
2. Coulam C. Edad, estrógenos y psique (Age, estrogens and psyche). Clin Obstet Ginecol 1981;1:225-233.
3. Sherwin B. The effect of sex steroids on brain mechanisms relating to mood and sexuality. In: Lorrain J, editor. Comprehensive management of menopause. New York: Springer-Verlag, 1993:327-333.
4. Depression in women. ACOG Technical Bulletin No. 182, July 1993. Int J Gynecol Obstet 1993;43:203-211.
5. Hay A, Bancroft J, Johnstone EC. Affective symptoms in women attending a menopause clinic. Br J Psychiatry 1994;164:513-516.
6. Kaufert PA, Gilbert P, Tate R. The Manitoba project, a re-examination of the link between menopause and depression. Maturitas 1992;14:143-155.
7. Pearlstein T, Rosen K, Stone AB. Mood disorders and menopause. Endocrinol Metab Clin North Am 1997; 26:279-294.
8. Coleman P. Depression during the female climacteric period. J Adv Nurs 1993;18:1540-1546.
9. Pearlstein TB. Hormones and depression: what are facts about premenstrual syndrome, menopause, and hormone replacement therapy? Am J Obstet Gynecol 1995;173:646-653.
10. Munaro NI. The effect of ovarian steroids on hypothalamic norepinephrine neuronal activity. Acta Endocrinol (Copenhagen) 1977;86:235-242.
11. Cotzias GC, Miller ST, Nicholson AR, Jr, Maston WH, Tang LC. Prolongation of the life-span in mice adapted to large amounts of L-dopa. Proc Natl Acad Sci USA 1974;71:2466-2469.
12. Lippert TH, Filshie M, Muck AO, Seeger H, Zwirner M. Serotonin metabolite excretion after postmenopausal estradiol therapy. Maturitas 1996;24:37-41.
13. Klaiber EL, Broverman DM, Vogel W, Kobayashi Y, Moriarty D. Effects of estrogen therapy on plasma MAO activity and EEG driving responses in depressed women. Am J Psychiatry 1972;128:1492-1498.
14. Zweifel JE, O'Brien WH. A meta analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 1997;22:189-212.
15. Korhonen S, Saarijarvi S. Oestradiol treatment helped a depressed postmenopausal woman to stop her psychotropic medication: a case report. Acta Psychiatr Scand 1996;94:480-481.
16. Pansini F, Albertazzi P, Banaccorsi G, Calisesi M, Campobasso C, Zanotti ? et al. The menopausal transition: a dynamic approach to the pathogenesis of neurovegetative complaints. Eur J Obstet Gynecol Reprod Biol 1994;57:103-109.
17. Palinkas L, Barret-Connor E. Estrogen use and depressive symptom in postmenopausal women. Obstet Gynecol 1992;80:30-36.
18. Sherwin B. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 1991;72:336-343.
19. Bailey J, Coppen A. A comparison between the Hamilton rating scale and the Beck inventory in the measurement of depression. Br J Psychiatry 1976;128:486-489.
20. Ramos-Brieva JA, Cordero-Villafafila A. A new validation of the Hamilton rating scale for depression. J Psychiatr Res 1988;22:21-28.